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Aim: Little is known about how patient groups provide information for patients. We invited 
838 patient groups from Europe and North America to participate in an online survey.  
 
Methods: The survey covered: (i) availability, accessibility and quality of information 
provided; (ii) methods by which patient groups communicate; (iii) ways in which patient 
groups acquire information and confirm its veracity/accuracy; (iv) how people access 
information online.   
 
Results: European patient groups were significantly less effective in providing medically-
related information than their North American counterparts in: Clinical Trials, Potential 
Causes of Cancer, Medical Research, Diagnosis/Screening, Symptoms, Treatments (all 
p<0.0001); Recommendations of best practice/care (p<0.03), Healthcare 
services(p=0.029) and Complimentary Medicine (p=0.01). Clinical Trials(p=0.0006), 
Medical Research(p=0.006) and Diagnosis/Screening(p=0.0024) were also areas where 
North American patients were more likely to require medically-related information.   
 
Similar patterns emerged for non-medical information with Nutrition(<0.0001), Watchful 
waiting(p=0.0003), Self-management of care(p=0.0003), Prevention(p=0.002) and 
Emotional issues(p=0.016) being less effectively communicated by European patient 
groups. Nutrition was also an area where North American patients were more likely to 
require non medically-related information 
 
The main barriers to accessing online information which showed differences between 
European and North American patients were:  Perceived Lack of need, mainly due to faith 
in their doctors (p=0.0001); Limited Access to the Internet (p = 0.0005), Limited Computer 
skills (p=0.02); and Lower Income (p=0.027). 
 
Conclusion: These results emphasise the more mature nature of cancer patient 
engagement/information provision in North America, providing valuable insights and 
guidance to inform  development of more robust and effective cancer patient information 
communication platforms in Europe. 
 
Keywords: Cancer patient information; Cancer patient groups; Patient survey; Barriers to 
accessing information 
 
 3 
 
Acknowledgements: We thank Jenni Byers for her help in preparing the Tables for the 
manuscript. This work was supported by European Union Framework Seven grant 
Eurocancercoms no: 230548. The funders had no role in the study design, data collection, 
analysis or interpretation of the data and preparation of, or decision to publish, the 
manuscript. 
 
  
 
 4 
 
Introduction  
Effective communication of information can underpin meaningful patient empowerment, 
while also embedding the patient’s perspective in cancer control efforts[1-5]. Access to 
information is the underlying principle of the 1st Article of the European Cancer Patient’s 
Bill of Rights, launched in the European Parliament on World Cancer Day 2014[6]. Tonio 
Borg, the European Commissioner for Health and Consumer Policy at the time,  praised  
this 1st Article, emphasising how “information is key to enable the patient to play an active 
role in his/her treatment, rather than just being a passive recipient[7].” However, the 
increasing volume and fragmentation of information, originating as it does from an array of 
sources, can often overwhelm patients[8. 9]. This “information overload” can hinder the 
patient’s appreciation of and contribution to the best option(s) for discovery science to be 
translated to patient-focussed clinical implementation. The exponential increase in data 
can confuse patients and citizens[10, 11], and this confusion, allied to potential distrust of 
particular information sources/providers, has led individuals to increasingly seeking help 
from patient groups. However, these patient groups may have been established to provide 
more general support, to focus on particular diseases, or to provide social assistance 
(including financial/legal help). Thus, they may lack relevant expertise to access, 
understand and provide co-ordinated, reliable, and robust information for the cancer 
patient.  
 
Publication of research through articles in scientific/medical journals, and its subsequent 
public dissemination, often happens via main-stream media, where key messages can 
frequently be unclear and/or distorted[12-15]. The majority of research is published in 
English; thus patients in non-English speaking countries will receive translated information 
which may not have the same detail or provide the particular nuance intended in the 
original text. Decisions on what mainstream media publishes/highlights are usually based 
on what makes a “good” or “bad” news story; this may not necessarily reflect the 
interests/needs of cancer patients or health professionals[16]. Cancers affecting a smaller 
percentage of the population, the so-called “Cinderella cancers”, tend to have lower media 
profiles than more highly prevalent and well-researched cancers such as breast, prostate 
and colorectal[17]. Innovative discoveries in rarer cancers such as  pancreatic, lymphoma, 
sarcoma may not be disseminated as effectively as those for more common cancers.  
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Increasingly, patients use the internet to obtain health information about their disease[18, 
19]. There is no single trusted source of information suitable for advocacy groups and 
patients[20]. Patients are faced with a plethora of websites and a babel of conflicting 
statements and claims. Thus, it is essential to better understand the strengths and 
weaknesses of current patient information provision from organisations serving the cancer 
community. In this study, we utilised a survey approach to gain important insights on the 
nature of the cancer patient information landscape.  
 
Methodology  
Data was collected from patient groups via an online survey. The survey was conducted in 
five languages: English, French, German, Italian, and Spanish. It was sent to all European 
patient groups listed in the world’s most comprehensive database (PatientView) as 
providing information for cancer patients(n=767). To allow benchmarking of the European 
data, the survey was also sent to patient groups based in North America (n=71). 
 
The survey covered five main areas: 
1. Availability and quality of information provided by patient groups; 
2. Methods by which patient groups communicate; 
3. Methodology which patient groups employ to collect reliable information; 
4. Criteria for standard setting for information being provided by patient groups; 
5. Use of online resources by people with an interest in cancer. 
 
Participants in European patient group survey 
A total of 571/767 patient groups responded to the survey. The largest number of 
respondents came from the UK, representing 32% of the total groups surveyed. A total of 
29% were umbrella groups for all cancers, 40% specialised in one or more common 
cancers, while 8% specialised in rare cancers. Nearly one quarter of groups (23%) had an 
interest in cancer, but cancer was not their main activity; the highest representation being 
from carer/family groups. 
 
European groups deliver a variety of services to patients. Almost all (97%) provided 
information to patients. European groups also supplied information primarily in their 
national language, though 56% of all groups supplied information in English. 
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Participants in North American patient group survey: 
A total of 68/71 patient groups responded to the survey. Of these, 87% were from the 
United States(US), with 13% from Canada. In total, 56% were umbrella groups for all 
cancers; 21% specialised in one or more common cancer, while 4% specialised in rare 
cancers. Nearly one fifth of groups (19%) had an interest in cancer, but cancer was not 
their main activity; the highest representation came from groups focusing on alternative 
therapies, carer/family groups and groups advocating for chronic disease. 
 
North American groups deliver a variety of services to patients. All (100%) provided 
information to patients. Aside from English, North American groups supplied information in 
Spanish and French. Some groups employed translators to maximise the reach of their 
information. 
 
Statistics 
Two-sample z-tests for the difference between proportions were conducted. Significance 
was set at the 0.05 level.  
 
Results  
Survey Completion rates 
A total of 838 patient groups (767 European/71 North American) with an interest in cancer 
were approached to participate. In the European arm, the survey was completed by 571 
participating groups (Completion rate: 74%) (Table 1). A total of 68 completed the North 
American arm (Completion rate: 96%) (p<0.001) (Table 1).  
 
Availability and Quality of information 
Overall, availability and quality of information for patients with cancer was judged ‘good’ to 
‘excellent’ by ~80% of respondents in Europe and just over 90% from North 
America(p=0.028) (Table 2a) . 
 
Provision of medically-related information was more limited in Europe compared with North 
America (Table 2b). Significant differences were detected in the following areas:  Clinical 
Trials(29% v 78%, p<0.0001), Potential Causes of Cancer(39% v 68%, p<0.0001), Medical 
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Research(25% v 52%, p<0.0001), Diagnosis/Screening (57% v 86%, p<0.0001), 
Symptoms (61% v 86%, p<0.0001), Treatments (61% v 86%, p<0.0001), 
Recommendations of best practice/care (49% v 63%, p<0.03), Healthcare services 45% v 
59%, p=0.029), and Complimentary Medicine (33% v 48%, p=0.01).  Of these areas, 
Clinical Trials(p=0.0006), Medical Research(p=0.006) and Diagnosis/ 
Screening(p=0.0024) were also indicated as significant areas where North American 
patients were more likely to require medically-related information (Table 2d).   
 
Provision of non-medically-related information was also more limited in Europe compared 
with North America (Table 2c). Significant differences were detected for information on 
Nutrition (55% v 83%, p<0.0001), Watchful waiting (27% v 48%, p=0.0003), Self 
Management of care (48% v 70%, p=0.0006),   Prevention (52% v 72%, p<0.002), and 
Emotional issues (70% v 84%, p=0.0016), although information on Travel insurance was 
more likely to be provided by European patient groups (22% v 8%, p=0.007).  
 
Interestingly, nutrition (43% v 66%, p=0.0003) was the only area  identified where North 
American patients were more likely to require non medically-related information (Table 
2e) while travel insurance (18% v 2%, p=0.0007) was the only area  identified where 
European  patients were more likely to require non medically-related information(Table 
2e). 
 
Methods of communication 
Patient groups in Europe and North America remain heavily reliant on non-electronic forms 
of communication (Table 3a). The most popular form is by printed leaflets (74% of 
European-based groups v 89% of North American-based groups, p=0.007,). Patient- or 
public-focused ‘events’ were the next most popular form of communication (71% v 81% 
respectively) but did not reach statistical significance (p=0.082). Specifically from a patient 
perspective, annual patient meetings, conferences and summits were less frequent in 
Europe than in North America (50% v 69% respectively, p=0.003)   Use of videos/DVDs 
(32% v 58% respectively, p<0.0001), Printed posters (43% v 61%, p=0.005), awareness-
raising campaigns (41% v 55%, p=0.027), discussion groups(55% v 74%, p=0.003) and 
posted letters(40% v 53%, p=0.04) were also less utilised in Europe compared to North 
America.  
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When European and North American patient groups were asked to indicate the primary 
information channel most important to their activities, the top three choices selected by 
European-based organizations were ‘annual patient meetings, conferences and summits’ 
(25%), ‘websites’ (17%) and telephone help-lines (10%) (Table 3b). By contrast, in North 
America, the top three choices were ‘websites’ (33%) (p=0.001), ‘annual patient meetings, 
conferences and summits’ (16%) and face-to-face advice (11%) (Table 3b). Overall, North 
American organisations had a greater proportion of information resources available online 
(67% v 54%, p=0.042, Table 3c) 
 
Gathering information  
European-based and North American-based patient groups showed differences in their 
source of information about cancer (Table 4)’ the following were statistically significant: 
Academic Bodies (62% V 45%, P=0.008), Conferences/seminars (61% v 74%, p=0.036), 
medical journals (54% v 69%, p=0.019), government bodies (38% v 52%, p=0.03).Patient-
specific information sources included  accessing information from other patient 
organisations (43% v 63%, p=0.002) and online discussion groups (16% v 30%, p=0.004) 
 
Setting standards for information 
Approximately two-thirds (66% v 71% p=ns, Table 5) of patient groups stated that they 
regularly updated their information. Additionally 61% v 60%, (p=ns, Table 5) indicated that 
they obtained feedback from patients to assure trustworthiness/reliability of information.  
However, the majority of North American-based patient groups also took the added 
precaution of having their own medical/scientific advisory group check the information 
(48% v 60%, p=0.06). An online certification body check (14% v 24%, p=0.03) did reach 
statistical significance (Table 5). 
 
Use of online resources  
In Europe(67%)   and North America(84%), people affected by cancer used websites as 
their main online resource to access information (p=0.004) (Table 6a). Email was also 
popular, with 43% v 71% of groups indicating that that they use it ‘most’ or ‘all’ of the time 
(p<0.0001), while use of social media (13% v 33%, p<0.0001) and  electronic 
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newsletters(21% v 42%, p=0.0001) were also less popular in Europe compared to North 
America.  (Table 6b). 
 
Access to online cancer information remains difficult for older people, people who do not 
speak the country’s main language, ethnic minorities, people with disabilities, and to a 
lesser extent European women (Table 6c). The main statistically significant barriers to 
patients seeking information online were: limited access to the Internet (84% v 67%, 
0.0005); limited computer skills (85% v 74%, p=0.02); lower income (41% v 55%, p=0.027) 
(Table 6d). Additionally, both  European and  North America patient groups speculated  
that people do not access information online because they perceive either no need and/or 
have total faith in medical professionals (30% v 53%, p=0.001).  
 
Discussion  
Patient groups from Europe and North America that participated in this study deliver a 
wide range of support to cancer patients, including provision of cancer and cancer-related 
information. However, there were marked differences in the types of   information that 
were made available and their mode(s) of delivery.  
 
From a medical perspective, North American patient groups were statistically more likely to 
provide information on clinical trials, possible causes of cancer, medical research, 
diagnosis/screening, symptoms of disease, types of treatment, recommendations of best 
care/practice, availability of healthcare services and use of complimentary medicines. Our 
data suggest that a more comprehensive menu of information should be provided by 
European patient groups. Additionally, European patients could be signposted to sources 
of accurate information (e.g. Cancer Research UK, European Cancer Patient Coalition, 
country-specific cancer societies). A small number of sites providing consistent and 
regularly updated information, translated into a series of different languages, may provide 
a more reliable resource, such that European cancer patients and their carers can make 
more informed decisions on their care, including their ability to access innovative clinical 
trials.   
 
A similar pattern emerged for issues not directly related to medical care, with North 
American patient groups statistically more likely to provide information on self-
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management of care, nutrition, prevention, emotional issues and watchful waiting. 
Capturing and providing this increasingly important information can help empower patients 
to recognise and deal with some of these non-medical issues and access appropriate 
services that will support the cancer patient during his/her journey. This is particularly 
relevant for the >14 million cancer survivors in Europe[21],   and as the number of people 
living with and beyond cancer increases, with an accompanying emphasis on care in the 
community, there will be a greater need for access to reliable information on sourcing 
appropriate services to help people cope with the physical, psychological or social 
sequelae of cancer[22. 23]. Travel insurance was the only area where European patients 
were more likely to receive information/advice, perhaps reflecting the lower propensity of 
American citizens in particular to travel outside the US.  
 
While both European and North American patient groups tended to use the internet 
(through their website) as their major mode of communication (with North American patient 
groups ranking it as their most important form of communication), it was also apparent that 
North American patient groups made significantly more use of printed leaflets, posters, 
annual patient summits/conferences, videos/DVDs, awareness campaigns, discussions 
groups and posted letters to deliver their communication message(s). Providing 
information through different sources and through different media (e.g. print, video, 
internet) is an important component of a patient-centred communication strategy, as 
different patients may have preferred modes of receiving, processing and acting on the 
information that they receive.  
 
Information sources varied between the survey constituencies but North American patient 
groups were statistically more likely to access information from conferences/seminars, 
academic bodies, government bodies, medical journals, other patient bodies and online 
discussion groups. They also employed certification bodies or expertise of medical 
professions (e.g. on their advisory group) to check the veracity of and ensure timely 
updates of information provided for cancer patients. It is important that robust, clear and 
unambiguous information is provided to patients and their carers, allowing them to make 
informed decisions that reflect the latest and most accurate information available.   
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Given the importance of providing online information sources, (with North American cancer 
patients statistically more likely to use websites, email, electronic newsletters or social 
media), we assessed the potential barriers to accessing information online. Limited access 
to the internet and limited computer skills were identified as the most statistically relevant 
barrier for European cancer patients, while North American cancer patients highlighted low 
income (which may indirectly identify challenges in relation to computer/online access) and 
a perceived lack of need due to confidence in their doctor/oncologist, as the principal 
barriers. Defining more precisely the computer skills and access gaps would allow more 
tailored training to be provided and online products to be designed for cancer patients, 
while also continuing to provide easy access to relevant material online, so that cancer 
patients have the opportunity to make an informed choice and participate in shared 
decision-making with their healthcare provider(s).   
 
Our study has certain limitations. It captures a particular moment in time, and rapid 
developments in patient-focused information sources and tools mean that information 
delivery for patients and their carers are constantly being refined and improved. The 
exponential increase in social media sites and activities is not directly captured, with its 
significant potential to allow patients to self-aggregate and share experiences online. 
Additionally, as we surveyed organisations who provide information, rather than patients 
who access this information, it is a subjective survey, albeit one with clearly defined 
questions whose results can be quantitatively assessed  
. 
Conclusion 
Our study identifies key components, activities and barriers that characterise the cancer 
patient information landscape in Europe and North America. It highlights how adoption of 
some of the best practices from North America may help create a buoyant information 
ecosystem that will enhance the European cancer patient’s ability to make key decisions 
that positively influence their cancer treatment and improve their Quality of Life as people 
living with and beyond cancer. 
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1. RESPONSE RATE 
Table 1: Response rate for European and North American participating organisations 
  Europe (%)  North America (%) z-value p 
Response rate* 74 96 4.1 <0.0001 
*significant at the p<0.05 level 
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2. AVAILABILITY AND QUALITY OF INFORMATION 
Table 2a: Rating of overall availability and quality of information provided 
   Europe (%)        North America 
(%) 
z-value        p 
‘Good’/’Excellent’             80 91 2.2 0.028 
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Table 2b: Provision of medically-related information 
 Europe (%) North America (%) z-value p 
Clinical Trials* 
Possible causes of cancer* 
Medical Research* 
Diagnosis and Screening* 
29 
39 
25 
57 
78 
68 
52 
86 
8.1 
4.6 
4.7 
4.6 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
Symptoms*  61 86 4.1 <0.0001 
Treatments* 61 86 4.1 <0.0001 
Recommendations of  
best practice/care* 
 49 63 2.2 0.03 
Healthcare services* 
Psychosocial support 
45 
59 
59 
67 
2.2 
1.3 
0.029 
0.20 
Palliative care  47 43 0.6 0.53 
Complementary 
Medicine* 
33 48 2.5 0.01 
*significant at the p<0.05 level 
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Table 2c: Provision of non-medical information 
 Europe (%) North America (%) z-value p 
Self-management of care* 48 70 3.4 0.0006 
Nutrition* 55 83 4.4 <0.0001 
Prevention *  52 72 3.1 0.002 
Emotional issues* 70 84 2.4 0.016 
Quality of life 72 80 1.4 0.16 
Relationships/Body image 50 56 0.9 0.35 
Economic/Social consequences  49 53 0.6 0.53 
Patients’ rights 56 52 0.6 0.53 
Employment issues  36 39 0.5 0.63 
Patient complaints procedures  32 34 0.3 0.74 
Spiritual issues  31 38 1.2 0.24 
Watchful waiting*  27 48 3.6 0.0003 
Legal issues  26 33 1.2 0.22 
Problems of discrimination  24 31 1.3 0.21 
Travel insurance*  22 8 2.7 0.007 
Stigma  16 25 1.9 0.06 
*significant at the p<0.05 level 
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Table 2d: Requirement for medically-related information by people affected with cancer 
 Europe (%) North America (%) z-value p 
Clinical Trials* 
Possible causes of cancer 
Medical Research * 
Diagnosis and Screening* 
10 
38 
12 
61 
24 
43 
24 
75 
3.4 
0.8 
2.8 
2.3 
 
0.0006 
0.423 
0.006 
0.024 
Symptoms  63 67 0.6 0.517 
Treatments 78   88 1.9 0.055 
Recommendations of best 
practice/care 
 47 52 0.8 0.435 
Healthcare services 
Psychosocial support 
44 
42 
54 
48 
1.6 
0.9 
0.117 
0.344 
Palliative care  27 17 1.8 0.075 
Complementary 
Medicine 
20 23 0.6 0.561 
*significant at the p<0.05 level 
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Table 2e: Requirement for non-medical information by people affected with cancer 
 Europe (%) North America (%) z-value p 
Self-management of care 37 48 1.8 0.077 
Nutrition* 43 66 3.6 0.0003 
Prevention  38 45 1.1 0.263 
Emotional issues 56 48 1.3 0.210 
Quality of life 58 68 1.6 0.113 
Relationships/Body image 36 27 1.5 0.141 
Economic/Social consequences  40 36 0.6 0.524 
Patients’ rights 24 16 1.5 0.139 
Employment issues  22 13 1.7 0.085 
Patient complaints procedures  8 8 0.0 1.000 
Spiritual issues  19 18 0.2 0.842 
Watchful waiting  16 23 1.5 0.144 
Legal issues  17 17 0.0 1.000 
Problems of discrimination*  10 2 2.2 0.031 
Travel insurance*  18 2 3.4 0.0007 
Stigma  9 7 0.6 0.582 
*significant at the p<0.05 level 
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3. METHODS OF COMMUNICATION 
Table 3a: Methods by which organisations communicated to patients 
 Europe (%) North America (%) z-value p 
Printed leaflet* 74 89 2.7 0.007 
Printed Posters* 
Patient/Public events  
43 
71 
61 
81 
2.8 
1.7 
0.005 
0.082 
Annual patient 
meetings/summits/conferences*  
50 69 3 0.003 
Video/DVD* 32 58 4.3 <0.0001 
Awareness Raising Campaigns* 
Discussion Groups* 
Letters in the post* 
Face-to-face advice  
41 
55 
40 
68 
55 
74 
53 
61 
2.2 
3 
2.1 
1.2 
0.027 
0.003 
0.040 
0.24 
Telephone Help Lines 
Press Releases 
Books 
Website 
64 
53 
38 
90 
61 
58 
48 
87 
0.5 
0.8 
1.6 
0.8 
0.62 
0.43 
0.11 
0.44 
Email 74 71 0.5 0.60 
*significant at the p<0.05 level 
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Table 3b: Primary information channels that were ranked most important by European/North 
American organisations(10% or greater for at least one of Europe or North America) 
 Europe 
(%) 
North 
America (%) 
z-value p 
Annual patient 
meetings/summits/conferences 
Websites* 
Telephone help lines 
Face-to-Face advice 
Awareness raising campaigns 
 
25 
 
17 
10 
6 
9 
16 
 
33 
3 
11 
10 
 
1.6 
 
3.2 
1.9 
1.6 
0.3 
0.1 
 
0.001 
TNA 
0.115 
0.786 
     
     
TNA Test not applicable 
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Table 3c: Proportion of information sources available online  
 Europe (%) North America (%) z-value p 
                                                                          54                          67  2.0  0.042 
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4. GATHERING INFORMATION 
Table 4a: Channels through which information was gathered for provision to patients 
 Europe (%) North America (%) z-value p 
Conferences/seminars* 61 74 2.1 0.036 
Board of trustees/medical 
subcommittee 
60 57 0.5 0.63 
Other health professionals 60 62 0.3 0.750 
Medical journals*  54 69 2.4 0.019 
From Patients known to us 
General Web searching 
Academic Bodies* 
Other Patient Organisations* 
Government bodies* 
Public Media 
Online Discussion Groups* 
Blogs 
Patient survey 
48 
46 
45 
43 
38 
28 
16 
2 
67 
55 
41 
62 
63 
52 
29 
30 
4 
62 
1.1 
0.8 
2.7 
3.1 
2.2 
0.2 
2.9 
1.1 
0.8 
0.28 
0.43 
0.008 
0.002 
0.03 
0.86 
0.004 
TNA 
0.41 
Patient focus groups  56 64 1.3 0.21 
Patient feedback forms  57 60 0.5 0.64 
*significant at the p<0.05 level, TNA Test not applicable 
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5. STANDARD SETTING FOR INFORMATION 
Table 5: Approaches organisations used to check/maintain quality and veracity of information 
provided to patients 
 Europe (%) North America (%) z-value p 
Regularly updated their 
information 
66 71 0.8 0.41 
Patient feedback  61 60 0.2 0.87 
Medical/advisory group check  
Through membership of umbrella 
organisation 
Board of Directors check 
Aligned Stakeholder body check 
Online Certification Body check* 
Pilot studies of patient opinions 
 
48 
41 
 
22 
16 
14 
13 
60 
40 
 
29 
16 
24 
12 
1.9 
0.2 
 
1.3 
0.0 
2.2 
0.2 
0.06 
0.87 
 
0.19 
1.00 
0.03 
0.82 
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6. USAGE OF INFORMATION 
Table 6a: Use of website as a social media tool 
 Europe (%) North America (%) z-value p 
‘Most’/’All’ of people affected by 
cancer used website as social media 
tool* 
66 85 3.2 0.002 
*significant at the p<0.05 level 
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Table 6b: Use of different social media tools to access information  
 Europe (%) North America (%) z-value p 
Websites*  67 84 2.9 0.004 
Email  43 71 4.4 <0.0001 
Electronic Newsletters  21 42 3.9 0.0001 
Social Media  13 33 4.4 <0.0001 
Internet chat fora 
Internet blogs 
Wikis 
Online petitions 
Photo/video sharing 
Live webcasting 
Podcasts 
Webinars 
10 
8 
7 
6 
4 
2 
1 
1 
20 
15 
5 
4 
8 
16 
0 
11 
2.5 
1.9 
0.6 
0.7 
1.5 
5.9 
0.8 
5.5 
0.013 
0.504 
TNA 
TNA 
TNA 
TNA 
TNA 
TNA 
TNA Test not applicable 
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Table 6c: Populations for which accessing the Internet was deemed difficult  
 Europe (%) North America (%) z-value p 
Older people  95 95 0 1 
Those who do not speak the 
main language of the country  
77 72 0.9 0.36 
Ethnic minorities  67 65 0.3 0.74 
Those with disabilities  66 61 0.8 0.41 
Women  
Men 
Carers 
People of working age 
Younger people 
51 
49 
48 
38 
20 
41 
45 
41 
27 
11 
1.6 
0.6 
1.1 
1.8 
1.8 
0.12 
0.53 
0.27 
0.08 
0.08 
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Table 6d: Barriers to seeking online information 
 Europe (%) North America (%) z-value p 
Limited computer skills** 85 74 2.3 0.02 
Limited access to Internet** 84 67 3.5 0.0005 
Limited access to computers/smart 
phones  
76 83 1.3 0.197 
Language  64 55 1.5 0.146 
Lower income*^  41 55 2.2 0.027 
Literacy problems  61 69 1.3 0.199 
Doubts about trustworthiness 
Fears about privacy 
Disability 
No need/faith in medical profession* 
35 
34 
33 
30 
39 
44 
39 
53 
0.7 
1.6 
1.0 
3.8 
0.515 
0.102 
0.322 
0.0001 
*significant at the p<0.05 level 
**higher barrier Europe 
^higher barrier North America 
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